French pharmaceuticals giant Sanofi has said that its Covid-19 vaccine, developed with Britain's GlaxoSmithKline, had delivered positive results after nearly a year of setbacks that left it lagging far behind its rivals.
The two drug makers said Wednesday that they will "seek regulatory authorisation" for their vaccine in the United States and the European Union following phase 3 trials involving thousands of people.
